Cargando…
Thrombogenicity of flow diverters in an ex vivo shunt model: effect of phosphorylcholine surface modification
BACKGROUND: Flow diverters offer a promising treatment for cerebral aneurysms. However, they have associated thromboembolic risks, mandating chronic dual antiplatelet therapy (DAPT). Shield Technology is a phosphorylcholine surface modification of the Pipeline Embolization Device (PED) flow diverter...
Autores principales: | Hagen, Matthew W, Girdhar, Gaurav, Wainwright, John, Hinds, Monica T |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5629931/ https://www.ncbi.nlm.nih.gov/pubmed/27799376 http://dx.doi.org/10.1136/neurintsurg-2016-012612 |
Ejemplares similares
-
Thrombogenicity assessment of Pipeline Flex, Pipeline Shield, and FRED flow diverters in an in vitro human blood physiological flow loop model
por: Girdhar, Gaurav, et al.
Publicado: (2018) -
Thrombogenicity assessment of Pipeline, Pipeline Shield, Derivo and P64 flow diverters in an in vitro pulsatile flow human blood loop model
por: Girdhar, Gaurav, et al.
Publicado: (2019) -
Acute thrombus formation on phosphorilcholine surface modified flow diverters
por: Marosfoi, Miklos, et al.
Publicado: (2018) -
Comparison of the Thrombogenicity of a Bare and Antithrombogenic Coated Flow Diverter in an In Vitro Flow Model
por: Lenz-Habijan, T., et al.
Publicado: (2019) -
Poly(2-methoxyethyl acrylate) (PMEA) improves the thromboresistance of FRED flow diverters: a thrombogenic evaluation of flow diverters with human blood under flow conditions
por: Yoshizawa, Keiko, et al.
Publicado: (2023)